The Asia-Pacific Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 10.9% over the forecast period (2021-2027). China, India, Japan, ASEAN, South Korea, and the Rest of Asia-Pacific are the key economies contributing to the growth of the market over the forecast period. The key aspect that drives the growth of the Asia-Pacific Interleukin Inhibitors market includes the rising geriatric population who are more prone to diseases such as arthritis and asthma. For instance, as per the United Nations (UN), in 2019, the percentage of the population aged 65 years and over in the country was 11.5%, which is expected to reach 16.9% by 2030. Hence, this is likely to create a wide scope for market growth in the region
To Request a Sample of our Report on Asia-Pacific Interleukin Inhibitors Market: https://www.omrglobal.com/request-sample/asia-pacific-interleukin-inhibitors-market
Both, China and India hold 40% of the total world population share. As the population of India and China grows, its expanding share of older adults is particularly notable. The United Nations Population Division projects that India’s population age 50 years and older will reach 34% by 2050. Between 2010 and 2050, the share of people aged over 65 and older is expected to increase from 5% to 14%, while the share in the oldest age group (80 and older) will triple from 1% to 3%. Hence, with the age dynamics, these people are more prone to diseases such as arthritis, asthma, and others. This, in turn, creates scope for the market growth over the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of Asia-Pacific Interleukin Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-interleukin-inhibitors-market
Market Coverage
- Market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- By Product Type and Applications
- Region Covered- Asia-Pacific
- Competitive Landscape- Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, AstraZeneca Plc, and Sun Pharmaceutical Industries Ltd. among others
Asia-Pacific Interleukin Inhibitors Market – Segmentation
By Product Type
- IL-1 Inhibitors
- IL-5 Inhibitors
- IL-6 Inhibitors
- IL-17 Inhibitors
- IL-23 Inhibitors
By Applications
- Arthritis
- Asthma
- Eczema
- Inflammatory Bowel Disease (IBD)
- Psoriasis
- Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
